Latest News and Press Releases

IGI Announces CRADA with National Cancer Institute to Test Proprietary Oral Cbl/b Inhibitor Treatment in Triple Negative Breast Cancer

Biosplice Announces Initiation of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) Trial Sponsored by the National Cancer Institute (NCI)

SAN FRANCISCO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- ProLynx Inc. announced today that the first patient was treated with PLX038 (PEGylated SN-38) in a Phase I/II clinical trial for primary CNS tumors...

FLORHAM PARK, N.J., April 12, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies...

FLORHAM PARK, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies...

NAIROBI, Kenya, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Catholic Medical Mission Board (CMMB) announced today that they have launched a cancer care project in Kitui South and Kitui Central sub-counties to...

Fourth RAS Initiative Symposium Highlights Preclinical Data in Solid Tumor Models CARLSBAD, Calif., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified...

CARLSBAD, Calif., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers...

WASHINGTON, D.C., Aug. 10, 2022 (GLOBE NEWSWIRE) -- The Cancer Support Community (CSC) enthusiastically supports President Biden’s selection of Monica Bertagnolli, MD to the position of director of...

FLAGSTAFF, Ariz., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Symple Surgical Inc. (SSI) announced today that it has received a Small Business Innovation Research (SBIR) Phase I grant award totaling...